Evidence map›Paper›PMID 18483851›Full record

ArticleBreast cancer research and treatment2009

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.

Ophira Ginsburg, Parviz Ghadirian, Jan Lubinski, Cezary Cybulski, Henry Lynch, Susan Neuhausen, Charmaine Kim-Sing, Mark Robson, Susan Domchek, Claudine Isaacs and 8 more

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer forCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  8. Cancers · 2018
    Review
  9. Article
  10. Cigarette smoking in women after BRCA1/2 genetic test disclosure: a 5-year follow-up study of the GENEPSO PS cohort.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Detoxification: a novel function of BRCA1 in tumor suppression?Toxicological sciences : an official journal of the Society of Toxicology · 2011
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 15 institutions in 5 countries.

Ophira GinsburgThe Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, Toronto, ON, Canada.
Parviz Ghadirian
Jan Lubinski
Cezary Cybulski
Henry Lynch
Susan Neuhausen
Charmaine Kim-Sing
Mark Robson
Susan Domchek
Claudine Isaacs
Jan Klijn
Susan Armel
William D Foulkes
Nadine Tung
Pal Moller
Ping Sun
Steven A Narod
Hereditary Breast Cancer Clinical Study Group
Pomeranian Medical University · PLWomen's College Hospital · CABC Cancer Agency · CABeth Israel Deaconess Hospital · USCreighton University · USGeorgetown University · USMcGill University · CAMemorial Sloan Kettering Cancer Center · USNorwegian Cancer Society · NOPrincess Margaret Cancer Centre · CARotterdam University of Applied Sciences · NLUniversité de Montréal · CAUniversity Health Network · CAUniversity of California System · USUniversity of Pennsylvania · US

Funding

GENETIC EPIDEMIOLOGY OF BREAST CANCER--BRCA1 AND BRCA2R01CA074415 · NCI · UNIVERSITY OF UTAH · PI NEUHAUSEN, SUSAN L. · 1998 to 2007
$3.9M
NCI NIH HHS R01 CA074415NCI NIH HHS R01 CA744175
6 · The paper itself

Abstract

Among women with a mutation in BRCA1 or BRCA2, the risk of breast cancer is high, but it may be modified by exogenous and endogenous factors. There is concern that exposure to carcinogens in cigarette smoke may increase the risk of cancer in mutation carriers. We conducted a matched case-control study of 2,538 cases of breast cancer among women with a BRCA1 (n = 1,920) or a BRCA2 (n = 618) mutation. One non-affected mutation carrier control was selected for each case, matched on mutation, country of birth, and year of birth. Odds ratios were calculated using conditional logistic regression, adjusted for oral contraceptive use and parity. Ever-smoking was not associated with an increased breast cancer risk among BRCA1 carriers (OR = 1.09; 95% CI 0.95-1.24) or among BRCA2 carriers (OR = 0.81; 95% CI 0.63-1.05). The result did not differ when cases were restricted to women who completed the questionnaire within two years of diagnosis. A modest, but significant increase in risk was seen among BRCA1 carriers with a past history of smoking (OR = 1.27; 95% CI 1.06-1.50), but not among current smokers (OR = 0.95; 0.81-1.12). There appears to be no increase in the risk of breast cancer associated with current smoking in BRCA1 or BRCA2 carriers. There is a possibility of an increased risk of breast cancer among BRCA1 carriers associated with past smoking. There may be different effects of carcinogens in BRCA mutation carriers, depending upon the timing of exposure.

Indexed as

Genes, BRCA1Genes, BRCA2AdolescentAdultAgedAged, 80 and overBreast NeoplasmsCase-Control StudiesFemaleHeterozygoteHumansMiddle AgedMutationRisk FactorsSmokingYoung Adult

Identifiers

PMID18483851
PMCPMC3033012
OpenAlexW2061224075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.